No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 14,392 | 16,414 | 18,715 | 21,888 | 20,837 | 18,962 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 144 | 117 | 52 | -171 | 100 | -280 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Jiangsu Yike Food Group Co.,Ltd specializes in the slaughter and preparation of poultry, serving both the domestic Chinese market and international clientele. The company boasts an extensive and varied product line. This encompasses a broad selection of duck items, including diverse duck blood preparations (such as braised, frozen, hot pot, and duck blood tofu) and numerous duck parts like tongues, legs, feet, gizzards, necks, livers, and whole or half ducks, along with duck jerky, duck intestines, and assorted duck skewers. Their chicken offerings are equally comprehensive, featuring breasts, feet, boneless options, wing roots, and various chicken chops (e.g., star, whirlwind, snowflake, Sichuan), grilled wings, chicken skin skewers, and cumin drumsticks. Beyond poultry, their product assortment also extends to complementary food items. These include different tofu products (dried, skin, yuba), vegetables and fungi like kelp knots, enoki mushrooms, marinated shiitake, lotus root slices, and seaweed strips. Their selection is further enhanced by an array of other skewered items, such as Australian skewers, beef skewers, and grilled sausage slices. In addition to its core food processing operations, Jiangsu Yike Food Group Co.,Ltd is actively involved in upstream poultry industry activities. This includes the manufacturing and distribution of animal feed and poultry seedlings, alongside commodity hatching and the breeding of both poultry and specific poultry breeds. Established in 2004, the firm maintains its corporate headquarters in Suqian, China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Jiangsu Yike Food Group Co.,Ltd (301116.SZ)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Jiangsu Yike Food Group Co.,Ltd specializes in the slaughter and preparation of poultry, serving both the domestic Chinese market and international clientele. The company boasts an extensive and varied product line. This encompasses a broad selection of duck items, including diverse duck blood preparations (such as braised, frozen, hot pot, and duck blood tofu) and numerous duck parts like tongues, legs, feet, gizzards, necks, livers, and whole or half ducks, along with duck jerky, duck intestines, and assorted duck skewers. Their chicken offerings are equally comprehensive, featuring breasts, feet, boneless options, wing roots, and various chicken chops (e.g., star, whirlwind, snowflake, Sichuan), grilled wings, chicken skin skewers, and cumin drumsticks. Beyond poultry, their product assortment also extends to complementary food items. These include different tofu products (dried, skin, yuba), vegetables and fungi like kelp knots, enoki mushrooms, marinated shiitake, lotus root slices, and seaweed strips. Their selection is further enhanced by an array of other skewered items, such as Australian skewers, beef skewers, and grilled sausage slices. In addition to its core food processing operations, Jiangsu Yike Food Group Co.,Ltd is actively involved in upstream poultry industry activities. This includes the manufacturing and distribution of animal feed and poultry seedlings, alongside commodity hatching and the breeding of both poultry and specific poultry breeds. Established in 2004, the firm maintains its corporate headquarters in Suqian, China.
